Event Overview

eyeforpharma's 5th Annual Patient Adherence & Persistence Summit USA

"Industry awareness of the importance of patient compliance has grown substantially during the last five years. eyeforpharma's 2007 US event is without doubt the one that provided you with both an overview of state-of-the-art approaches and pragmatic industry solutions"
Len Starnes , Head of Global E-Business , Bayer Schering

Following on from 4 years of highly successful Global Pharmaceutical Patient Compliance conferences eyeforpharma's latest offering in this field guarantees you the insights, strategies and contacts you need to drive Patient Adehrence and measure ROI in complex and changing environment.

Experts estimate that patient non-adherence costs the pharmaceutical industry in excess of $30 billion a year – not to mention, the chance at a fuller, healthier life for countless patients.

Clinical researchers estimate that for most prescribed drugs, patient compliance rates are 50-60%, but with some disease states, compliance drops as low as 10-20%. So, even modest improvements in adherence can have significant impacts on not only revenues for drug makers, but expenses for third party payers and outcomes for patients.

Improving compliance is a win-win for everyone in the patient care equation.

Is your company prepared to meet the challenge and discover the opportunity of improved patient adherence and persistence?

KEY POINTS TO BE ADDRESSED AT THE SUMMIT :

Multi-Stakeholder Collaboration : How closer ties with payers, disease management providers, chain drugstores and other key stakeholders will help you overcome the costly problem of non-compliance in your patient groups

Product Managers: Realise the long term sense of compliance strategies for your ROI!

Latest Industry Case Studies: Hear how to mix tools and marketing channels to build patient commitment

State-of-the-Art Technology: Learn how to refresh traditional tools, including reminder services to improve your compliance program

Developing Patient Relations : Learn how to develop a fully integrated program, and leverage the value from different patient segments

Explore Patient Level Data : Learn whose taking your drug and why, understand how PLD can increase your understanding of your customer

Strengthen the Patient-Physician Relationship Discover how small changes in physician behavior will result in improved levels of adherence and persistence

Cutting Edge Educational Programs: Do Nurse Call Centres provide sufficient ROI? Analyze the benefits of this live interaction

Measure ROI: Best Practice guidelines for proving effectiveness of adherence programs

Please send your ideas, suggestions and proposals to Kate Eversole on keversole@eyeforpharma.com or call me on +44 (0) 207 375 7594 US TOLL FREE +1 800 814 3459 ext 296

Here are a few of last years speakers:

Cathy Mecker , Global Marketing Director for Patient Adherence, Eli Lilly and Company
David Baker , Vice President & General Manager, ADHD Business Unit, Shire
Steve Basiago , Vice President, Trade Relations, Walgreens Health Services
Melody Boyd , Head of Clinical R & D, Intercytex
Sandipa Dublish , Director, Oncology Market Research, Bristol Myers Squibb
Murat V. Kalayoglu , MD, PhD, Harvard University
Dr. Andrea LaFountain , Senior Manager, Consumer Insights, AstraZeneca
Craig Lipset , Director, Health Technologies, Pfizer
Pablo Przygoda , Product Manager, Patient Initiatives, Actelion
Marc Rovner , Managing Director, SmartAnalyst, formerly, VP, Global New Markets, Johnson & Johnson
Michael Sokol , Director, Disease Management, GlaxoSmithKline
Rachel Bevis , APC Director of Marketing Strategy, AstraZeneca